547 related articles for article (PubMed ID: 30248941)
1. The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers.
Varghese E; Samuel SM; Abotaleb M; Cheema S; Mamtani R; Büsselberg D
Cancers (Basel); 2018 Sep; 10(10):. PubMed ID: 30248941
[TBL] [Abstract][Full Text] [Related]
2. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
Fatima I; El-Ayachi I; Taotao L; Lillo MA; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA
PLoS One; 2017; 12(12):e0189864. PubMed ID: 29281678
[TBL] [Abstract][Full Text] [Related]
3. Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells.
Varghese E; Samuel SM; Varghese S; Cheema S; Mamtani R; Büsselberg D
Biomolecules; 2018 Dec; 8(4):. PubMed ID: 30563138
[TBL] [Abstract][Full Text] [Related]
4. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
5. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways.
Almatroodi SA; Alsahli MA; Almatroudi A; Verma AK; Aloliqi A; Allemailem KS; Khan AA; Rahmani AH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33804548
[TBL] [Abstract][Full Text] [Related]
6. Challenges and perspectives in the treatment of diabetes associated breast cancer.
Samuel SM; Varghese E; Varghese S; Büsselberg D
Cancer Treat Rev; 2018 Nov; 70():98-111. PubMed ID: 30130687
[TBL] [Abstract][Full Text] [Related]
7. NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers.
Poma P; Labbozzetta M; D'Alessandro N; Notarbartolo M
OMICS; 2017 Apr; 21(4):225-231. PubMed ID: 28388298
[TBL] [Abstract][Full Text] [Related]
8. Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy.
Samuel SM; Varghese E; Satheesh NJ; Triggle CR; Büsselberg D
Biomed Pharmacother; 2023 Aug; 164():114911. PubMed ID: 37224753
[TBL] [Abstract][Full Text] [Related]
9. The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer.
Ke DYJ; El-Sahli S; Wang L
Curr Cancer Drug Targets; 2022; 22(5):388-403. PubMed ID: 34970954
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers.
Kaushik V; Azad N; Yakisich JS; Iyer AK
Cell Death Discov; 2017; 3():17009. PubMed ID: 28250972
[TBL] [Abstract][Full Text] [Related]
11. Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway.
Sharma P; Khan MA; Najmi AK; Chaturvedi S; Akhtar M
Med Oncol; 2022 Oct; 39(12):248. PubMed ID: 36209343
[TBL] [Abstract][Full Text] [Related]
12. Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
Coussy F; El Botty R; Lavigne M; Gu C; Fuhrmann L; Briaux A; de Koning L; Dahmani A; Montaudon E; Morisset L; Huguet L; Sourd L; Painsec P; Chateau-Joubert S; Larcher T; Vacher S; Melaabi S; Salomon AV; Marangoni E; Bieche I
J Hematol Oncol; 2020 Feb; 13(1):13. PubMed ID: 32087759
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds.
Ang HL; Mohan CD; Shanmugam MK; Leong HC; Makvandi P; Rangappa KS; Bishayee A; Kumar AP; Sethi G
Med Res Rev; 2023 Jul; 43(4):1141-1200. PubMed ID: 36929669
[TBL] [Abstract][Full Text] [Related]
14. The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
Oh YJ; Park SY; Seo YH
Oncol Rep; 2018 Apr; 39(4):1775-1782. PubMed ID: 29436674
[TBL] [Abstract][Full Text] [Related]
15. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
Wu HT; Lin J; Liu YE; Chen HF; Hsu KW; Lin SH; Peng KY; Lin KJ; Hsieh CC; Chen DR
Phytomedicine; 2021 Jan; 81():153437. PubMed ID: 33352494
[TBL] [Abstract][Full Text] [Related]
16. Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway.
Li J; Gong X; Jiang R; Lin D; Zhou T; Zhang A; Li H; Zhang X; Wan J; Kuang G; Li H
Front Pharmacol; 2018; 9():772. PubMed ID: 30108501
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells.
Yunokawa M; Koizumi F; Kitamura Y; Katanasaka Y; Okamoto N; Kodaira M; Yonemori K; Shimizu C; Ando M; Masutomi K; Yoshida T; Fujiwara Y; Tamura K
Cancer Sci; 2012 Sep; 103(9):1665-71. PubMed ID: 22703543
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer.
Wright TD; Raybuck C; Bhatt A; Monlish D; Chakrabarty S; Wendekier K; Gartland N; Gupta M; Burow ME; Flaherty PT; Cavanaugh JE
J Cell Biochem; 2020 Feb; 121(2):1156-1168. PubMed ID: 31464004
[TBL] [Abstract][Full Text] [Related]
19. Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.
Koleckova M; Ehrmann J; Bouchal J; Janikova M; Brisudova A; Srovnal J; Staffova K; Svoboda M; Slaby O; Radova L; Vomackova K; Melichar B; Veverkova L; Kolar Z
Sci Rep; 2021 Mar; 11(1):5145. PubMed ID: 33664322
[TBL] [Abstract][Full Text] [Related]
20. Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling.
Shahi Thakuri P; Gupta M; Singh S; Joshi R; Glasgow E; Lekan A; Agarwal S; Luker GD; Tavana H
BMC Cancer; 2020 Jan; 20(1):4. PubMed ID: 31898540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
